InvAscent: Investment advisor for growth capital funds, fueling India's healthcare and pharma sectors.
Location
Hyderabad, Andhra Pradesh, IN
Founded
2006
InvAscent is an investment advisor specializing in growth capital for the Indian pharmaceutical, healthcare, animal health, and medtech sectors. They manage funds such as EILSF, India Life Sciences Fund II (ILSF-II), and India Life Sciences Fund III (ILSF-III), typically investing between USD 10 - 40 million over the life of the investment. Their focus is on providing private equity to support capacity expansion, new product introductions, and acquisitions.
Notable portfolio companies include Malladi Drugs, which has raised $2.5 billion. InvAscent's key partners are experienced in the healthcare and pharmaceutical industries, offering strategic guidance and leveraging extensive networks to add value beyond capital. Their investment philosophy centers on fostering growth and innovation within India's life sciences sector, ensuring sustainable development and competitive advantage for their portfolio companies.
InvAscent - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
